Physiological potential of cytokines and liver damages

Abstract

Cytokines are soluble extracellular small molecular weight protein or peptide. They are produced by virtually every nucleated cell type in response to injurious stimuli to control body metabolism, infection, inflammation and tissue or neuronal damage; therefore acting as messengers between tissues and the immune system; and participating in many physiological processes through their either anti-inflammatory or pro-inflammatory characteristics. Many cytokines have multiple cellular sources and targets, as well as many natural inducers and inhibitors. In pathophysiological conditions and during the early phase of chronic liver diseases, agent like virus, bacteria, parasites, ethanol, or toxins, induce secretion of cytokines at high levels. The presence of cytokine antagonists and soluble cytokine receptors, often released in concert with their respective cytokine agonist, presents additional complexity to interpretation.

Keywords

Cytokines / liver diseases / oxidative stress / inflammation

References

[1] Guven-Maiorov E,Keskin O,Nussinov R.Structural pathways of cytokines may iluminate their roles in regulation of cancer development and immunotherapy..Cancers (Basel)2014;6:663-83 PMCID:PMC4074797

[2] Ai W,Song N,Chen H.Optimal method to stimulate cytokine production and its use in immunotoxicity assessment..Int J Environ Res Public Health2013;10:3834-42 PMCID:PMC3799516

[3] Sultani M,Bowen JM.Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy induced gastrointestinal mucositis..Chemother Res Pract2012;2012:490804

[4] Allavena P.Marchesi F, Mantovani, A. Chemokines in cancer related inflammation..Exp Cell Res2011;317:664-73

[5] Matei I.Cytokine patterns and pathogenicity in autoimmune disease..Rom J Intern Med2002;40:27-41

[6] Pasha HF,Hagrass HA,Emara MH.Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy..Cytokine2013;61:478-84

[7] Cohen MC.Cytokine function: a study in biologic diversity..Am J Clin Pathol1996;105:589-98

[8] Ikram N,Tufail S.Cytokines..Int J Pathol2004;2:47-58

[9] SekIyama KD,Thomson AW.Circulating proinflammatory cytokines (IL-ll3, TNF-a, and IL-6) and IL-1 receptor antagonist (IL-lRa) in fulminant hepatic failure and acute hepatitis..Clin Exp Immunol1994;98:71-7 PMCID:PMC1534161

[10] Oppenheim JJ.Cytokines: past, present, and future..Int J Hematol2001;74:3-8

[11] Slifka MK.Clinical implication of dysregulated cytokine production..J Mol Med (Berl)2000;78:74-80

[12] Angkasekwinai P.TH17 Cytokines: Characteristics, Regulation, and Biological Function.In: Jiang S, editor. TH17 Cells in Health and Disease. Berlin: Springer Science+Business Media LLC; 2011

[13] Racanelli V.The liver as an immunological organ..Hepatology2006;43:S54-62

[14] Arend WP,Guthridge CJ.Interleukin-1 receptor antagonist: role in biology..Annu Rev Immunol1998;16:27-55

[15] Symons JA,Duff GW.Soluble type II interleukin I (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist..Proc Natl Acad Sci U S A1995;92:1714-8 PMCID:PMC42590

[16] Ceni E,Galli A.Pathogenesis of alcoholic liver disease: Role of oxidative metabolism..World J Gastroenterol2014;20:17756-72 PMCID:PMC4273126

[17] McClain CJ,Barve SS,Deaciuc I.Recent advances in alcoholic liver disease: IV- Dysregulated cytokine metabolism in alcoholic liver disease..Am J Physiol Gastrointest Liver Physiol2004;287:G497-502

[18] Kitazawa T,Fujimoto M,Uemura M.The production of tumor necrosis factor-a by macrophages in rats with acute alcohol loading..Alcohol Clin Exp Res2003;27:S72-5

[19] Tsujimoto T,Yamazaki M,Okuda H,Fukui H.Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers..Int J Oncol2001;18:41-7

[20] Bilzer M,Gerbes AL.Role of Kupffer cells in host defense and liver disease..Liver Int2006;26:1175-86

[21] Diehl AM.Recent events in alcoholic liver disease: V. Effects of ethanol on liver regeneration..Am J Physiol Gastrointest Liver Physiol2005;288:G1-6

[22] Aldred ND.Ethanol dissociates hormone stimulated cAMP production from inhibition of TNF-a production in rat Kupffer cells..Am J Physiol1999;276:G98-106

[23] Hill DB,Cohen D,Shedlofsky S.Increased plasma interleukin-6 concentrations in alcoholic hepatitis..J Lab Clin Med1992;119:547-52

[24] Akriviadis E,Briggs W,Reynolds T.Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial..Gastroenterology2000;119:1637-48

[25] Tilg H,Kaser A,Offner FA,Ludwiczek O,Zoller H,Mookerjee RP,Datz C,Schuppan D,Vogel W.Anti-tumor necrosis factor alpha monoclonal antibody therapy in severe alcoholic hepatitis..J Hepatol2003;38:419-25

[26] Hong F,Tian Z,Ishac E,Gao B.Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins..Oncogene2002;21:32-43

[27] Gao B.Cytokines, STATs and liver disease..Cell Mol Immunol2005;2:92-100

[28] Kasztelan-Szczerbińska B,Celiński K,Zwolak A,and Szczerbiński M.Prognostic significance of the systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences..PLoS One2015;10:e0128347

[29] Zhang X,Wang H,Williams GM,Sun Z.Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice..Hepatology2010;52:2137-47 PMCID:PMC2991528

[30] Lemmers A,Gustot T,Degré D,de Nadai P,Quertinmont E,Le Moine O.The interleukin-17 pathway is involved in human alcoholic liver disease..Hepatology2009;49:646-57

[31] Petrasek J,Csak T,Kodys K,Barrieau M,Kurt-Jones EA.IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice..J Clin Invest2012;122:3476-89 PMCID:PMC3461900

[32] Abd El-Kader SM.Non-alcoholic fatty liver disease: the diagnosis and management..World J Hepatol2015;7:846-58 PMCID:PMC4411527

[33] Lalor PF,Aarbodem Y,Adams DH.The role of cytokines and chemokines in the development of steatohepatitis..Semin Liver Dis2007;27:173-93

[34] Brenner DA,Angel P,Karin M.Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha..Nature1989;337:661-3

[35] Olteanu S,Shaish A,Shemesh S,Apte RN,Kamari Y.Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice..Dig Liver Dis2014;46:433-9

[36] Ikejima K,Kon K,Sato N.Role of adipocytokines in hepatic fibrogenesis..J Gastroenterol Hepatol2007;S87-92

[37] Rajala MW.Minireview: The adipocyte-at the cross roads of energy homeostasis, inflammation, and atherosclerosis..Endocrinology2003;144:3765-73

[38] Bruun JM,Verdich C,Toubro S,Richelsen B.Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans..Am J Physiol Endocrinol Metab2003;285:E527-33

[39] Hukshorn CJ,Toet KH,Eilers PH,Kooistra T.Leptin and the proinflammatory state associated with human obesity..J Clin Endocrinol Metab2004;89:1773-8

[40] You T,Rayan S.Effect of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese post-menopausal women..J Clin Endocrinol Metab2004;89:1739-46

[41] Pravo PE,Borne DM,Reisin E.Leptin and hypertension..Vasc Health Risk Manag2006;2:163-9

[42] Popper H.Cholestasis: the future of a past and present riddle..Hepatology1981;1:187-91

[43] Keith G,Rej R.Burtis CA,Tietz NW.Liver function..Tietz Textobook of Clinical Chemistry, Volume 3, Chapter 33.1999;Philadelphia, PAW.B. Saunders

[44] Spirlì C,Duner E,Ballardini G,Larusso NF,Okolicsanyi L.Cytokine-stimulated nitric oxide production inhibits adenyl cyclase and cAMP-dependent secretion in cholangiocytes..Gastroenterology2003;124:737-53

[45] Ahmed HH.Curcumin as an effective agent against ethinylestradiol-induced hepatocellular cholestaris..Egypt J Med Lab Sci2004;13:1-16

[46] Jaeschke H,Cederbaum AI,Pessayre D.Mechanism of hepatotoxicity..Toxicol Sci2002;65:166-76

[47] Sträter J.Pathogenesis of primary biliary cirrhosis: CD 95-induced apoptosis at last?.Eur J Gastroenterol Hepatol1998;10:539-41

[48] Fox ES,Tracy TF.NF-Kappa β activation and modulation in hepatic macrophages during cholestatic injury..J Surg Res1997;72:129-34

[49] Ferrari C,Galati L,Scaccaglia P,Schianchi C,Marin MG.T-cell response to structural and non-structural hepatitis C virus antigen in persistent and self limited hepatitis C virus infection..Hepatology1994;19:286-95

[50] Abd-Elghaffar Y,Eid A.Effect of interferon-α therapy on oxidative stress in hepatitis C virus infection..Arab J Lab Med1999;25:345-54

[51] Lee J,Chan ST,Cho C.TNF-α induced by hepatitis C virus via TLR7 and TLR8 in hepatocytes supports interferon signaling via an autocrine mechanism..PLoS Pathog2015;11:e1004937

[52] Zalata AA,Atwa AA.Relationship between S-Adenosylmethionine, S-Adenosylhomocysteine, Tumor necrosis factor-α, reduced glutathione and nitrite in liver cirrhosis..Egypt J Biochem Molecular boil2007;25:362-82

[53] Nessim I,Moussa M,Hazem A,Abdel-Hadi A,El-Ghafir W.Implication of tumor-necrosis factor alpha (TNF-α): Interleukin-1 Beta (IL1-β) and intercellular adhesion molecule-1 (ICAM-1) in warm hepatic ischaemia-reperfusion injury: Effect of intraportal infusion of prostaglandin E-1..Egypt J Lab Med2002;14:243-74

[54] Martínez-Esparza M,Ruiz-Alcaraz AJ.Inflammatory status in human hepatic cirrhosis..World J Gastroenterol2015;21:11522-41 PMCID:PMC4631958

[55] Koziel MJ,Afdhal N,Rice CM,Houghton M.HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release..J Clin Invest1995;96:2311-21 PMCID:PMC185882

[56] Lechmann M,Langhans B,Ihlenfeldt HG,Sauerbruch T.Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C..J Hepatol1999;31:971-8

[57] Cribier B,Rey D,Kirn A.Production of cytokines in patients infected by hepatitis C virus..J Med Virol1998;55:89-91

[58] McGuinness PH,Davies S.Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection..Gut2000;46:260-9 PMCID:PMC1727823

[59] Gonzalez-Flecha B,Cutrin JC,Boveris A.Oxidative stress produced by suprahepatic occlusion and reperfusion..Hepatology1993;18:881-9

[60] Goossens V,Devos K.Direct evidence for tumor necrosis factor induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity..Proc Nat Acad USA1995;92:8115-9

[61] Lefkowitch JH,Davis GL,Lindsay K,Balart LA,Payne J,Gibas A,Tamburro CH,O'Brien C,Van Thiel DH,Albrecht J,Sanghvi B.Pathological diagnosis of chronic hepatitis C: a multicenter comparative study in chronic hepatitis B..Gastroenterology1993;104:595-603

[62] Mandelker L.Oxidative stress, free radicals, and cellular damage.In: Mandelker L, Vajdovich P, editors. Studied on Veterinary Medicine.2011;BerlinSpringer Science+Business Media LLC1-18

[63] Jia B,Li G,Zhang X,Deng Q.Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase Kinase 7..J Virol2015;89:2041-51 PMCID:PMC4338861

[64] Wieland SF,Chisari FV.Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice..J Virol2000;74:4165-73 PMCID:PMC111931

[65] Lok AS.Hepatitis B infection: pathogenesis and management..J Hepatol2000;32:89-97

[66] Cavanaugh VJ,Chisari FV.Interleukin-12 inhibits hepatitis B virus replication in transgenic mice..J Virol1997;71:3236-43

[67] Li Z,Liu Q.Activation of CXCL-8 Transcription by hepatitis E virus ORF-1 via AP-1..Mediators Inflamm2015;2015:495370 PMCID:PMC4436455

[68] Kumar A,Kar P,Husain SA,Sharma S.Association of cytokines in hepatitis E with pregnancy outcome..Cytokine2014;65:95-104

[69] Iarotski LS.The schistosomiasis problem in the world: results of a WHO questionnaire survey..Bull World Health Organ1981;59:115-27

[70] Duan Y,Zhu D,Chen J,Song K,He X.Schistosoma japonicum soluble egg antigens induce apoptosis and inhibit activation of hepatic stellate cells: a possible molecular mechanism..Int J Parasitol2014;44:217-24

[71] Huang J,Li L,Xu L,Fan X,Ning Q.Involvement of heat shock protein 47 in Schistosoma japonicum-induced hepatic fibrosis in mice..Int J Parasitol2014;44:23-35

[72] Wynn TA.Fibrotic disease and the T(H)1/T(H)2 paradigm..Nat Rev Immunol2004;4:583-94 PMCID:PMC2702150

[73] Silveira-Lemos D,Martins-Filho OA,Costa-Silva MF,de Souza LJ,Correˆa-Oliveira R.Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients..Acta Trop2008;108:150-9

[74] Wilson MS,Pesce JT,Thompson R.Immunopathology of schistosomiasis..Immunol Cell Biol2007;85:148-54 PMCID:PMC3437548

[75] Mwatha JK,Kamau T,Ouma JH,Fulford AJ,Butterworth AE,Dunne DW.High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human Schistosomiasis mansoni..J Immunol1998;160:1992-9

[76] Sombetzki M,Fickert P,Mueller M,Loebermann M,Langner C,Schwinge D,Schramm C,Reisinger EC.24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis..J Hepatol2015;62:871-8 PMCID:PMC4368108

[77] Hou X,Man S,Zhang Y,Ren C.Polyinosinic-polycytidylic acid attenuates hepatic fibrosis in C57BL/6 mice with Schistosoma japonicum infection..Acta Trop2012;121:99-104

[78] Ferri S,De Molo C,Muratori P,Hussain MJ,Lenzi M,Bianchi FB,Muratori L.A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis..Hepatology2010;52:999-1007

[79] Holder BS,Liberal R,Heneghan MA,Vergani D.Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2..J Autoimmun2014;53:26-32

[80] Cherٌavsky AC,Rubio AE,Periolo N,Goٌi J,Caٌero-Velasco MC,Fainboim H.Simultaneous expression of Thl cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children..Hum Immunol2004;65:683-91

[81] Moritoki Y,Ohsugi Y,Gershwin ME.B cells and autoimmune liver diseases..Autoimmun Rev2006;5:449-57

[82] Solari NEF,Cuarterolo M,Fernلndez-Salazar L,Garrote J.The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis..Clin Immunol2010;137:396-405

[83] Gresner AM.The up-and-down of hepatic stellate cells in tissue injury: apoptosis restores cellular homeostasis..Gastroenterology2001;120:1285-8

[84] Iredale JP,Pickering J,Northrop M,Hovell C.Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors..J Clin Invest1998;102:538-49 PMCID:PMC508915

[85] Gressner AM.Liver fibrosis: perspectives in pathobiochemical research and clinical outlook..Eur J Clin Chem Clin Biochem1991;29:293-311

[86] Svegliati Baroni G,Ferretti G,Di Sario A,Ridolfi F,Jezequel AM.Fibrogenic effect of oxidative stress on rat hepatic stellate cells..Hepatology1998;27:720-6

[87] Thirunavukkarasu C,Harvey SAK.Superoxide-induced apoptosis of activated rat hepatic stellate cells..J Hepatol2004;41:567-75

[88] Bataller R.Liver fibrosis..J Clin Invest2005;115:209-18 PMCID:PMC546435

[89] Yee LJ,Herrera J,van Leeuwen DJ.Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection..Genes Immun2000;1:386-90

[90] Bataller R,Brenner DA.Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal..Hepatology2003;37:493-503

[91] Han YP,Wang J,Garner WL,Tsukamoto H.Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen..J Biol Chem2004;279:4820-8 PMCID:PMC2430939

[92] Marek B,Mazurek U,Kos-Kudla B,Fila A,Beniowski M,Borgiel-Marek H,Sieminska L,Wilczok T,Filipczyk P.TGF-beta l mRNA expression in liver biopsy specimens and TGF-beta l serum levels in patients with chronic hepatitis C before and after antiviral therapy..J Clin Pharm Ther2005;30:271-7

[93] Nelson DR,Lau Y J.Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders..Gastroenterology2000;118:655-60

[94] Jacobson Brown PM.Immunopathogenesis of hepatitis C viral infection: Thl/Th2 responses and the role of cytokines..Clin Biochem2001;34:167-71

[95] Goyal A,Sakhuja P,Arora N.Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus..J Med Virol2004;72:60-5

[96] Cacciarelli TV,Gish RG,Krams SM.Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreatment with interferon alfa..Hepatology1996;24:6-9

[97] Lu DH,Qin SY,Huang XL,Wang JX,Yang XW.Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines..World J Gastroenterol2015;21:1531-45 PMCID:PMC4316095

[98] Hsia CY,Chiang SY,Sun CL,Lee PC,Lui WY.Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers of hepatocellular carcinoma..Eur J Surg Oncol2007;33:208-12

[99] El-Medany OM,Abu Shady EA.Chronic liver disease and hepatitis C virus in Egyptian patients..Hepatogastroenterology1999;46:1895-903

[100] Stoll-Keller F,Thumann C,Aubertin AM.Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches..Bull Acad Natl Med2003;187:1147-60; discussion 1160-1(in French)

[101] Elrefaei M,Kamal K.HCV-specific CD27- CD28- memory T cells are depleted in hepatitis C virus and Schistosoma mansoni co-infection..Immunology2003;110:513-8 PMCID:PMC1783079

[102] Marotta F,Cecere A.The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect..Clin Ter2004;155:187-99

[103] Lee S.Cytokines in cancer immunotherapy..Cancers (Basel)2011;3:3856-93 PMCID:PMC3763400

[104] Fainboim L,Paladino N,Arruvito L.Cytokines and chronic liver disease..Cytokine Growth Factor Rev2007;18:143-57